InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Salas Eduardo Rene. Insider active across 2 companies, notably Intra-Cellular Therapies, Inc.. Cumulatively, 4 reports have been recorded. History available since 19 February 2025. The latest transaction was filed on 9 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Salas Eduardo Rene is a declarant and a director at Adma Biologics, INC. and Intra-Cellular Therapies, Inc., both listed on XNAS. Across 4 filings in total, the recent filings we hold cover the period from 2024-06-25 to 2026-02-11, with 0 in purchases and 189614 in sales, and the most common transaction nature is Attribution.